Statin Therapy and Risk of Incident Diabetes Mellitus in Adults with Cardiovascular Risk Factors
Go AS, Ambrosy AP, Kevin Khede K, et al.
The American Journal of Cardiology. Pub online 19 November 2019
Leggi
Novità dal 22° Congresso Nazionale AMD
Comunicati stampa: 27 novembre: Diabete tipo 2, fino a 4 anni per avere la cura migliore: alleanza Italia-Usa per battere l’inerzia terapeutica 28 novembre: Diabete tipo 1: pazienti sempre più hi-tech, il 17% usa un microinfusore. Continua l’evoluzione verso il Pancreas Artificiale Simposio ADA-AMD sull’inerzia terapeutica - Sabato 30 novembre: Scarica…
Leggi
Cumulative Average Dietary Pattern Scores in Young Adulthood and Risk of Incident Type 2 Diabetes: The CARDIA Study
Hirahatake KM, Jacobs DR, Shikany JM, et al.
Diabetologia. 2019,62:2233-44
Leggi
Echocardiography Improves Prediction of Major Adverse Cardiovascular Events in A Population with Type 1 Diabetes and Without Known Heart Disease: The Thousand & 1 Study
Jensen MT, Sogaard P, Gustafsson I, et al.
Diabetologia. 2019,62:2354-64
Leggi
Addressing Bias in Artificial Intelligence in Health Care
Parikh RB, Teeple S, Navathe AS
JAMA. Pub online 22 November 2019
Leggi
Associations of Short Stature and Components of Height with Incidence of Type 2 Diabetes: Mediating Effects of Cardiometabolic Risk Factors
Wittenbecher C, Kuxhaus O, Boeing H, et al.
Diabetologia. 2019,62:2211-21
Leggi
Lifecycle Regulation of Artificial Intelligence– and Machine Learning–Based Software Devices in Medicine
Hwang TJ, Kesselheim AS, Vokinger KN
JAMA. Pub online 22 November 2019
Leggi
Machine Learning, Predictive Analytics, and Clinical Practice – Can the Past Inform the Present?
Peterson ED
JAMA. Pub online 22 November 2019
Leggi
Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions
McBurney MI, Davis C, Fraser CM, et al.
J Nutr. 2019;149(11):1882-95
Leggi